Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia

Human Psychopharmacology

Volumn 20, Issue 1, 2005, Pages 41-45

  Jung, Hee Yeon ^a,b   Kim, Jong Hoon ^c   Ahn, Yong Min ^a,d   Kim, Seong Chan ^a,d   Hwang, Samuel S ^d   Kim, Yong Sik ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Akathisia; Antipsychotic agents; Liverpool University Neuroleptic Side Effect Rating Scale; Parkinsonism

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; MOOD STABILIZER; OLANZAPINE;

ADULT; AKATHISIA; ARTICLE; BRADYKINESIA; COLD INJURY; CONCENTRATION LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIAGNOSTIC ACCURACY; DREAM; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EMOTIONAL DISORDER; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; FLUSHING; GAIT DISORDER; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; MOUTH ULCER; MUSCLE SPASM; MUSCLE STIFFNESS; NAIL DISEASE; OPEN STUDY; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; RESTLESSNESS; RIGIDITY; SALIVATION DISORDER; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SKIN DISEASE; SLEEP DISORDER; TENSION; TREMOR;

ADULT; AKATHISIA, DRUG-INDUCED; BASAL GANGLIA DISEASES; BENZODIAZEPINES; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PARKINSON DISEASE, SECONDARY; PATIENT PARTICIPATION; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 13644258202     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.655     Document Type: Article

References (20)

1. Ahn YM, Koh KB, Koo YJ, et al. 2002. The study for switching methods to olanzapine in Korean schizophrenic patients treated with other antipsychotics (I) - comparison of therapeutic efficacy. J Korean Neuropsychiatr Assoc 41: 876-889.
2. Ahn YM, Kweon YS, Kwon JS, et al. 2003. The study for switching methods to olanzapine in Korean schizophrenic patients treated with other antipsychotics (II) - comparison of safety. J Korean Neuropsychiatr Assoc 42: 79-88.
3. Awad AG, Voruganti LN. 2000. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull 26: 557-564.
4. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
5. Day JC, Kinderman P, Bentall R. 1998. A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation. Acta Psychiatr Scand 97: 93-97.
6. Day JC, Wood G, Dewey M, Bentall RP. 1995. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 166: 650-653.
7. Gerlach J, Larsen EB. 1999. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatr Scand Suppl 395: 113-117.
8. Jung HY, Joo YH, Shin HK, et al. 2002. A validation study of Korean-version of Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS). J Korean Neuropsychiatr Assoc 41: 138-145.
9. Kim JH, Byun HJ. 2003. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects. Clin Neuropharmacol 26: 312-316.
10. Kim JH, Lee BC, Park HJ, Ahn YM, Kang UG, Kim YS. 2002. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Compr Psychiatry 43: 456-462.
11. Lambert TJR, Cock N, Alcock J, Kelly DL, Conley RR. 2003. Measurement of antipsychotic-induced side effects: support for the validity of self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol Clin Exp 18: 405-411.
12. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen Y, 1987. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334: 1-100.
13. Morrison P, Gaskill D, Meehan T, et al. 2000a. The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. Aust N Z J Ment Health Nurs 9 166-176.
14. Morrison P, Meehan T, Gaskill D, Lunney P, Collings P. 2000b. Enhancing case managers' skills in the assessment and management of antipsychotic medication side-effects. Aust N Z J Psychiatry 34 814-821.
15. Naber D, Moritz S, Lambert M, et al. 2001. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 50: 79-88.
16. Owens DGC (ed.). 1999. A Guide to The Extrapyramidal Side-effects of Antipsychotic Drugs. Cambridge University Press: Cambridge.
17. Peralta V, Cuesta MJ. 1999. Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res 40: 245-253.
18. Simpson GM, Angus JW. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11-19.
19. Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Zirul S, Awad A. 2000. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 43: 135-145.
20. Yi JS, Ahn YM, Shin HK, et al. 2001. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 40: 1090-1105.